Israel Active

Israel’s DiA Imaging Analysis (reported previously) uses its AI image analysis of ultrasound scans to detect cardiac problems.  DiA has received a NIS 2.5 million grant from the Israel Innovation Authority to roll out its system to hospitals treating coronavirus patients.

Surgeons at Israel’s Save a Child’s Heart performed open heart surgery on two-year-old Hamza Ali Mohammed, who was born with life-threatening congenital heart disease. He has been hospitalized during the coronavirus pandemic but has now returned to his family in Ramallah.

Israeli biotech Gamida Cell published positive results in its Phase 3, 50-center trial of NiCord (now called Omidubicel) that aims to increase the success of bone marrow transplants in blood cancer patients. The stem cells were established much quicker than alternatives.

Israel’s Sheba Medical Center has inaugurated a new intensive care unit with hundreds of beds to provide crisis response in future national emergencies. A significant donation for the unit was received from philanthropist Roman Abramovich, a long-time donor of Sheba Medical Center.

Emergency service Magen David Adom and its 24,000 volunteers were critical to Israel’s pandemic strategy. Its trained volunteer call center handled over 100,000 calls a day and it minimized hospitalizations by testing 240,000 patients away from hospitals.

The US FDA has allowed the use of technology developed by Israel’s Aidoc Medical.to detect lung anomalies in CT-scans that are associated with coronavirus (Covid-19). It provides early detection of infected patients who show no coronavirus symptoms.

The 22-year-old critical coronavirus patient who woke from a 3-week coma in April has now begun rehabilitation at Sheba hospital.

The Israel Institute for Biological Research in Ness Ziona has developed four antibodies that attack the coronavirus and neutralize it in the body of an infected person. It is described as Israel’s “Manhattan Project” to defeat the Covid-19 pandemic. Trials and production planning have begun.

Israeli researchers have devised a sniff-test using shampoo and rotten fish, to determine if brain-injured patients have a chance of recovery. If the patient showed a predictable response, that person had a 100% chance of recovering consciousness and a 92% chance of surviving 3+ years.

The Israeli-developed Gammora HIV treatment is being used to treat HIV patients at the Cliniquie La Source hospital in the Congo. Those also with coronavirus significantly improved from both infections. A subsequent WHO-supervised study has confirmed the findings.